Evidence map›Paper›PMID 19244528›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2009

Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons.

Rajarshi Sengupta, Silvia Burbassi, Saori Shimizu, Silvia Cappello, Richard B Vallee, Joshua B Rubin, Olimpia Meucci

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. CXCL12 Engages Cortical Inhibitory Neurons to Enhance Dendritic Spine Plasticity and Structured Network Activity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  4. Article
  5. The Endolysosomal Transporter DMT1 is Required for Morphine Regulation of Neuronal Ferritin Heavy Chain.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Article
  6. Article
  7. Article
  8. Reactive Oxygen Species (ROS) are Critical for Morphine Exacerbation of HIV-1 gp120-Induced Pain.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2021
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Opioid Modulation of Neuronal Iron and Potential Contributions to NeuroHIV.Methods in molecular biology (Clifton, N.J.) · 2021
    Review
  15. Ferritins in Kidney Disease.Seminars in nephrology · 2020
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Rajarshi SenguptaDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, USA.
Silvia Burbassi
Saori Shimizu
Silvia Cappello
Richard B Vallee
Joshua B Rubin
Olimpia Meucci
Drexel University · USColumbia University Irving Medical Center · USWashington University in St. Louis · US

Funding

Role of chemokine receptors in neuronal survivalR01DA015014 · NIDA · MCP HAHNEMANN UNIVERSITY · PI MEUCCI, OLIMPIA · 2001 to 2017
$4.3M
Role of chemokines in neuronal function and survivalR37DA015014 · NIDA · DREXEL UNIVERSITY · PI Olimpia Meucci · 2018 to 2026
$3.7M
Cellular and Molecular Mechanisms of HIV NeuropathologyR01DA019808 · NIDA · DREXEL UNIVERSITY · PI MEUCCI, OLIMPIA · 2004 to 2008
$1.8M
SIGNALING EVENTS IN STROMAL REGULATION OF BRAIN TUMOR GROWTHR01CA118389 · NCI · WASHINGTON UNIVERSITY · PI RUBIN, JOSHUA B · 2007 to 2011
$1.4M
NCI NIH HHS R01 CA118389NIDA NIH HHS DA15014NIDA NIH HHS DA19808NIDA NIH HHS R01 DA015014NIDA NIH HHS R01 DA019808NIDA NIH HHS R37 DA015014PHS HHS NCI 118389
6 · The paper itself

Abstract

This study focuses on the effect of mu-opioid receptor agonists on CXCR4 signaling in neurons and the mechanisms involved in regulation of neuronal CXCR4 by opiates. The data show that CXCR4 is negatively modulated by long-term morphine treatments both in vitro and in vivo; CXCR4 inhibition is caused by direct stimulation of mu-opioid receptors in neurons, leading to alterations of ligand-induced CXCR4 phosphorylation and upregulation of protein ferritin heavy chain (FHC), a negative intracellular regulator of CXCR4. Reduced coupling of CXCR4 to G-proteins was found in the brain of morphine-treated rats, primarily cortex and hippocampus. CXCR4-induced G alpha(i)/G betagamma activities were suppressed after 24 h treatment of cortical neurons with morphine or the selective mu-opioid agonist DAMGO (D-Ala2-N-Me-Phe(4)-glycol(5)-enkephalin), as shown by analysis of downstream targets of CXCR4 (i.e., cAMP, Akt, and ERK1/2). These agonists also prevented CXCL12-induced phosphorylation of CXCR4, indicating a deficit of CXCR4 activation in these conditions. Indeed, morphine (or DAMGO) inhibited prosurvival signaling in neurons. These effects are not attributable to a reduction in CXCR4 expression or surface levels but rather to upregulation of FHC by opioids. The crucial role of FHC in inhibition of neuronal CXCR4 was confirmed by in vitro and in vivo RNA interference studies. Overall, these findings suggest that opiates interfere with normal CXCR4 function in the brain. By this mechanism, opiates could reduce the neuroprotective functions of CXCR4 and exacerbate neuropathology in opiate abusers who are affected by neuroinflammatory/infectious disorders, including neuroAIDS.

Indexed as

Analysis of VarianceAnimalsApoferritinsBenzylaminesBrainChemokine CXCL12CyclamsCyclic AMPDose-Response Relationship, DrugEmbryo, MammalianEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Enzyme InhibitorsGene Expression RegulationGuanosine 5'-O-(3-Thiotriphosphate)Heterocyclic CompoundsMorphineApoferritinsBenzylaminesChemokine CXCL12Cxcr4 protein, ratCyclamsCyclic AMPEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Enzyme InhibitorsGuanosine 5'-O-(3-Thiotriphosphate)Heterocyclic CompoundsMorphineNarcoticsplerixaforReceptors, CXCR4

Identifiers

PMID19244528
PMCPMC2664553
OpenAlexW2039662811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.